How severe is CVE-2024-27110?

CVE-2024-27110 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2024-27110 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.

How do I fix CVE-2024-27110?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2024-27110 have an EU (EUVD) identifier?

Yes. CVE-2024-27110 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-24360.

When was CVE-2024-27110 published?

CVE-2024-27110 was published on 2024-05-14 and last updated on 2026-06-17.

CVE-2024-27110

CVE-2024-27110 is a high-severity vulnerability with a CVSS 3.x base score of 8.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-250.

Key facts

Severity: High (CVSS 3.x base score 8.4)
EPSS exploit prediction: 0% (21st percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-24360
Weakness: CWE-250
Published: 2024-05-14
Last modified: 2026-06-17

Description

Elevation of privilege vulnerability in GE HealthCare EchoPAC products

Frequently asked questions

What is CVE-2024-27110?: Elevation of privilege vulnerability in GE HealthCare EchoPAC products
How severe is CVE-2024-27110?: CVE-2024-27110 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-27110 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-27110?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2024-27110 have an EU (EUVD) identifier?: Yes. CVE-2024-27110 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-24360.
When was CVE-2024-27110 published?: CVE-2024-27110 was published on 2024-05-14 and last updated on 2026-06-17.

References

https://securityupdate.gehealthcare.com/

Other CWE-250 vulnerabilities

CVE-2026-4606 — Critical (CVSS 10.0): GV Edge Recording Manager (ERM) v2.3.1 improperly runs application components with SYSTEM-level privileges, allowing…
CVE-2022-2634 — Critical (CVSS 10.0): An attacker may be able to execute malicious actions due to the lack of device access protections and device…
CVE-2026-48584 — Critical (CVSS 9.9): Execution with unnecessary privileges in Azure Synapse allows an authorized attacker to elevate privileges over a…
CVE-2026-50566 — Critical (CVSS 9.9): Fission is an open-source, Kubernetes-native serverless framework that simplifies the deployment of functions and…
CVE-2026-44477 — Critical (CVSS 9.9): CloudNativePG is a platform designed to manage PostgreSQL databases within Kubernetes environments. Prior to 1.29.1 and…
CVE-2026-25212 — Critical (CVSS 9.9): An issue was discovered in Percona PMM before 3.7. Because an internal database user retains specific superuser…

Browse all CWE-250 vulnerabilities →